{"id":5987,"date":"2018-01-27T19:38:21","date_gmt":"2018-01-27T19:38:21","guid":{"rendered":"https:\/\/www.ftcguardian.com\/articles\/?p=5987"},"modified":"2018-01-27T19:38:21","modified_gmt":"2018-01-27T19:38:21","slug":"marketers-barred-from-making-deceptive-claims-about-products-ability-to-mitigate-side-effects-of-cancer-treatment","status":"publish","type":"post","link":"https:\/\/www.ftcguardian.com\/articles\/marketers-barred-from-making-deceptive-claims-about-products-ability-to-mitigate-side-effects-of-cancer-treatment\/","title":{"rendered":"Marketers Barred from Making Deceptive Claims about Products Ability to Mitigate Side Effects of Cancer Treatment"},"content":{"rendered":"<h2>Marketers Barred from Making Deceptive Claims about Products Ability to Mitigate Side Effects of Cancer Treatment<\/h2>\n<p>By\u00a0<a href=\"http:\/\/www.imperialvalleynews.com\/index.php\/news\/latest-news\/13388-marketers-barred-from-making-deceptive-claims-about-products-ability-to-mitigate-side-effects-of-cancer-treatment.html\">IVN<\/a><\/p>\n<p>CellMark Biopharma, LLC and its CEO have agreed to settle Federal Trade Commission charges that they made false or unsupported claims regarding two health products they marketed as effective treatments for cancer patients\u2019 malnutrition and \u201cchemo fog,\u201d or treatment-related cognitive dysfunction.<\/p>\n<p><a class=\"popup_7TLM_Cheat_Sheet\" data-toggle=\"modal\" data-target=\"#popup_7TLM_Cheat_Sheet_modal\" href=\"#\"><img decoding=\"async\" class=\"aligncenter\" src=\"\/images\/button_banner-7TLM_Cheat_Sheet.png\" alt=\"\" \/><\/a><\/p>\n<p>According to the Commission\u2019s complaint, CellMark and its CEO, Derek E. Vest, violated the FTC Act by deceptively advertising two products for cancer patients: CellAssure, to treat cancer-related malnutrition, and Cognify, to treat \u201cchemo fog.\u201d A one-month supply of CellAssure sold for $248 and a one-month supply of Cognify sold for $79.<\/p>\n<p>The FTC alleges that the defendants advertised the two products with a range of deceptive and unsupported health benefits for cancer patients. For example, the defendants described CellAssure as a medical breakthrough solution that \u201cspecifically addresses the malnutrition suffered by over 80% of all cancer patients\u201d and claimed that CellAssure treats cancer with its \u201canti-cancer and anti-tumor properties.\u201d<\/p>\n<p>Read full article and learn more about <a href=\"http:\/\/www.imperialvalleynews.com\/index.php\/news\/latest-news\/13388-marketers-barred-from-making-deceptive-claims-about-products-ability-to-mitigate-side-effects-of-cancer-treatment.html\">Deceptive Advertising here<\/a>.<\/p>\n<p><a href=\"http:\/\/go.ftcguardian.com\/bw4uoy\"><img decoding=\"async\" src=\"https:\/\/s3.amazonaws.com\/ftcguardian\/images\/728x90-Un-vjy-FTC-GUARDIAN-banner-2.gif\" \/><\/a><\/p>\n<h2>Here\u2019s How To Make Sure You,\u00a0Your Business & Website Is FTC Compliant<\/h2>\n<p>By now it should be clear how important it is for you to be FTC compliant. But how can you do that without spending $7,500-$8,000 or more on Internet Attorneys?<\/p>\n<p>Smart business owners around the world are doing it with the help of FTC Guardian.<\/p>\n<p>FTC Guardian is a service that is 100% focused on helping to keep you get and stay FTC compliant and fully protected.\u00a0<a href=\"https:\/\/go.ftcguardian.com\/bw4uoy\" target=\"_blank\" rel=\"noopener noreferrer\">And right now, we are offering a free training to give you the knowledge, information, and guidance that you need to stay out of trouble with the Federal Trade Commission.<\/a><\/p>\n<p>Free Compliance Workshop:\u00a0<a href=\"https:\/\/go.ftcguardian.com\/bw4uoy\" target=\"_blank\" rel=\"noopener\"><strong>Join Chip Cooper, Esq., the #1 FTC Compliance trainer in the World, for a one-of-kind, completely free online compliance workshop. Workshops fill up quickly, so register now.<\/strong><\/a><\/p>\n<p>Here are some of the things you\u2019ll discover on the training:<\/p>\n<ul>\n<li>Real-Life Examples of People Who Didn\u2019t Think They Were At Risk, But Who Got Nailed By The FTC, And Why It Could Happen To You, Too<\/li>\n<\/ul>\n<ul>\n<li>The 3 Enormous Powers The FTC Has That Can Change Your Life \u2013 And Your Family\u2019s Life \u2013 Forever!<\/li>\n<\/ul>\n<ul>\n<li>How to Avoid FTC Claims When Collecting Leads With Optin Forms<\/li>\n<\/ul>\n<ul>\n<li>3 Privacy Policy Mistakes Every Digital Marketer Is Making, And Why You\u2019re In The FTC\u00a0Crosshairs.<\/li>\n<\/ul>\n<ul>\n<li>And Much More\u2026<\/li>\n<\/ul>\n<p><b>Remember: legal protection is a massively important part of your business, and it\u2019s one you cannot afford to ignore any longer.<\/b><\/p>\n<p><a href=\"https:\/\/go.ftcguardian.com\/bw4uoy\" target=\"_blank\" rel=\"noopener noreferrer\">Go here to register for our next FREE training and make your business is FTC compliant today!<\/a><\/p>\n<p><b>Disclaimer: \u00a0This article is provided for informational purposes only. It\u2019s not legal advice, and no attorney-client relationship is created. Neither the author nor FTC Guardian, Inc. is endorsed by the Federal Trade Commission.<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Marketers Barred from Making Deceptive Claims about Products Ability to Mitigate Side Effects of Cancer Treatment By\u00a0IVN CellMark Biopharma, LLC and its CEO have agreed to settle Federal Trade Commission charges that they made false or unsupported claims regarding two &hellip;  <\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_analytify_skip_tracking":false,"footnotes":""},"categories":[19,2,12,29],"tags":[11,33,54,21,28,15,30],"class_list":["post-5987","post","type-post","status-publish","format-standard","hentry","category-deceptive-advertising","category-ftc-claims","category-ftc-compliance","category-truth-in-advertising","tag-ad-claims","tag-advertising","tag-compliance-ftc","tag-deceptive-advertising","tag-federal-trade-commission","tag-ftc-compliance","tag-truth-in-advertising"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts\/5987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/comments?post=5987"}],"version-history":[{"count":2,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts\/5987\/revisions"}],"predecessor-version":[{"id":6033,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/posts\/5987\/revisions\/6033"}],"wp:attachment":[{"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/media?parent=5987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/categories?post=5987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ftcguardian.com\/articles\/wp-json\/wp\/v2\/tags?post=5987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}